Mechanism of 150-cavity formation in influenza neuraminidase

Rommie E Amaro1, Robert V Swift, Lane Votapka

  • 1Department of Pharmaceutical Sciences, Computer Science and Chemistry, University of California, Irvine, California 92697, USA. ramaro@uci.edu

Nature Communications
|July 14, 2011
PubMed

Insights

Influenza neuraminidase (NA) drug targets are key to combating antiviral resistance. Biophysical simulations reveal the 2009 H1N1 NA preferentially exists with an open 150-cavity, crucial for drug development.

Area of Science:

  • Virology
  • Structural Biology
  • Drug Discovery

Background:

  • Influenza A neuraminidase (NA) is a target for antiviral drugs.
  • Antiviral resistance is an increasing problem in influenza treatment.
  • The 150-cavity in group-1 NA proteins is a potential drug target.

Purpose of the Study:

  • To investigate the solution structure of 2009 H1N1 pandemic virus neuraminidase (09N1 NA).
  • To understand the structural basis for the presence or absence of the 150-cavity in 09N1 NA.
  • To identify factors stabilizing the 150-cavity for drug design.

Main Methods:

  • Biophysical simulations (1.6 μs total).
  • Comparative simulations with avian N1, human N2, and a mutated 09N1.
  • Bioinformatics analysis.

Main Results:

  • 09N1 NA exists preferentially with an open 150-cavity in solution.
  • A conserved salt bridge is crucial for stabilizing the 150-cavity.
  • This stabilization is observed across different NA subtypes.

Conclusions:

  • The 150-cavity is present in solution for 09N1 NA, contrary to crystal structures.
  • Structural understanding of the 150-cavity aids in developing antivirals against resistant strains.
  • Antiviral compounds targeting the 150-cavity can inactivate both pandemic H1N1 and avian H5N1 viruses.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
SN2 Reaction: Mechanism02:27

SN2 Reaction: Mechanism

The kinetic studies of SN2 reactions suggest an essential feature of its mechanism: it is a single-step process without intermediates. Here, both the nucleophile and the substrate participate in the rate-determining step.
The presence of the more electronegative halogen in the substrate creates a polarized carbon-halide bond. The halide pulls the electron cloud generating an electrophilic center at the carbon atom. Thus, the carbon atom carries a partial positive charge while the halide has a...